Laura Vasquez-Bolanos, PhD (@laurasvbb) 's Twitter Profile
Laura Vasquez-Bolanos, PhD

@laurasvbb

@loyalfordogs Head of Special Projects, Bioeng PhD, First gen, Latina 🇨🇴, Sloan Scholar, @NSFGRFP Fellow

ID: 973041335522529280

calendar_today12-03-2018 03:41:47

274 Tweet

336 Takipçi

610 Takip Edilen

Laura Vasquez-Bolanos, PhD (@laurasvbb) 's Twitter Profile Photo

The HRV change on the first day of my period is wild according to Oura. Essentially doubling the avg values. Speaks to the sharp estrogen and progesterone decline 🤔

Laura Vasquez-Bolanos, PhD (@laurasvbb) 's Twitter Profile Photo

The biggest push back on repurposing existing drugs for the longevity space is that it isn’t profitable. Especially if the drug is already cheap, What incentives could change this?

Laura Vasquez-Bolanos, PhD (@laurasvbb) 's Twitter Profile Photo

Is birth control helping or hurting your fertility? ncbi.nlm.nih.gov/pmc/articles/P… Should we be thinking of birth control differently -> focus on not depleting ovarian reserve

Celine Halioua (@celinehalioua) 's Twitter Profile Photo

Loyal’s drug for senior dog lifespan extension drug LOY-002 has completed its FDA efficacy package (RXE) We are on track to hopefully bring the first longevity drug to market *this year* Thanks Lisa Bonos + The Washington Post for the exclusive

Loyal’s drug for senior dog lifespan extension drug LOY-002 has completed its FDA efficacy package (RXE)

We are on track to hopefully bring the first longevity drug to market *this year*

Thanks <a href="/lisabonos/">Lisa Bonos</a> + <a href="/washingtonpost/">The Washington Post</a> for the exclusive